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Introduction
The  secretory  pathway  is  permanently  challenged  by  large 
amounts of newly synthesized proteins and lipids that need to be 
correctly sorted and transported. The first transport step is initi-
ated by the incorporation of secretory proteins into COPII (coat 
protein II)-coated vesicles budding from the ER (Bonifacino and 
Glick, 2004; Lee et al., 2004). COPII coat assembly starts by acti-
vation of the small GTPase Sar1 by its exchange factor Sec12. 
Active Sar1 on ER membranes mediates the recruitment of the 
COPII subunits Sec23-Sec24 and Sec31-Sec13, which induces 
COPII vesicle budding. In mammalian cells, COPII vesicles form 
at ribosome-free transitional elements of the rough ER, termed 
ER exit sites (ERESs; Orci et al., 1991; Zeuschner et al., 2006). 
Thus, COPII proteins are faithful markers for ERESs. Sec16 also 
localizes to ERESs and plays a central role in the organization of 
ERESs and COPII vesicle biogenesis (Supek et al., 2002; Watson 
et al., 2006; Bhattacharyya and Glick, 2007; Iinuma et al., 2007; 
Farhan et al., 2008).
In mammals, COPII vesicles mediate cargo transport to 
the ER–Golgi intermediate compartment (ERGIC), where de-
cisions are made either to recycle proteins back to the ER via 
COPI vesicles or to transport them on to the Golgi (Appenzeller-
Herzog and Hauri, 2006). Retrograde transport from Golgi to 
ER is also mediated by COPI vesicles (Letourneur et al., 1994) 
and involves passage through the ERGIC, at least partially. 
Thus, the ERGIC is an intermediary station in bidirectional 
ER–Golgi trafficking.
In contrast to the advanced knowledge of the mechanisms 
underlying vesicular trafficking, it remains largely unknown to 
what extent the secretory pathway is regulated by cellular signal-
ing pathways. A limited number of kinases and phosphatases 
have been implicated in the regulation of the early secretory pathway 
T
o what extent the secretory pathway is regulated 
by cellular signaling is unknown. In this study, we 
used RNA interference to explore the function of 
human kinases and phosphatases in controlling the organ­
ization of and trafficking within the secretory pathway. 
We  identified  122  kinases/phosphatases  that  affect   
endoplasmic reticulum (ER) export, ER exit sites (ERESs), 
and/or the Golgi apparatus. Numerous kinases/phos­
phatases regulate the number of ERESs and ER to Golgi 
protein trafficking. Among the pathways identified, the 
Raf–MEK  (MAPK/ERK  [extracellular  signal­regulated   
kinase] kinase)–ERK cascade, including its regulatory pro­
teins CNK1 (connector enhancer of the kinase suppres­
sor of Ras­1) and neurofibromin, controls the number of   
ERESs via ERK2, which targets Sec16, a key regulator of 
ERESs and COPII (coat protein II) vesicle biogenesis. Our 
analysis reveals an unanticipated complexity of kinase/
phosphatase­mediated regulation of the secretory path­
way, uncovering a link between growth factor signaling 
and ER export.
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did not fit into the ER or Golgi class. Our screen retrieved the 
known kinase regulators of intracellular trafficking, PCTAIRE1/
PCTK1, MST4, PIK4CA, and SCYL1. Silencing PCTAIRE1/
PCTK1 reduces the number of ERESs (Palmer et al., 2005), 
which is consistent with our finding that PCTK1 is an ER-class 
hit exhibiting a reduced number of peripheral ERGIC punctae 
(Table S2) and ERESs. Silencing MST4 disrupts Golgi morphol-
ogy (Preisinger et al., 2004). In our screen, we identified MST4 
as a Golgi-class hit with fragmented Golgi (Table S2). We previ-
ously showed that a knockdown of PIK4CA (PI4-kinase III) 
affects ERES number and ERES adaptation to cargo load (Farhan 
et al., 2008). In the current screen, PIK4CA was identified as a 
mixed-class hit with a reduced number of peripheral ERGIC 
punctae (Table S2) and slight fragmentation of the Golgi (not 
depicted). Finally, SCYL1 has been shown to bind COPI and to 
be involved in retrograde Golgi to ER transport (Burman et al., 
2008). In the current work, SCYL1 appeared as a mixed-class hit 
that reduced the number of peripheral ERGIC punctae (Table S2) 
and tubulated the Golgi (Fig. 1 E). Thus, besides the few known 
kinases, our screen identified a large number of novel potential 
regulators of the early secretory pathway.
Functional predictions from  
network analysis
ER- and Golgi-class hits were assembled into a network using 
the STRING database (http://string.embl.de/; Jensen et al., 
2009). ER-class hits were well connected (Fig. 2 A), whereas 
Golgi-class  hits  were  not  (Fig.  2  B). The  connectivity  of   
ER-class hits enabled us to perform functional annotation clus-
tering using the DAVID database (http://david.abcc.ncifcrf.gov/; 
Huang et al., 2009). We searched for specific enrichment of our 
hits within signaling pathways. ER-class hits were associated with 
13 different pathways. Nine ER-class hits were annotated to the 
MAPK pathway (Fig. 2 C). The mitogenic and the stress signaling 
pathways involving MAPKs are illustrated in Fig. S1 A. Interest-
ingly, the mitogenic MAPK signaling pathway only included 
ER-class hits. Lipid kinases were over-represented (26% of the 
lipid kinome vs. 14% of the protein kinome), which is consis-
tent with the fact that we are studying membrane trafficking. 
The  phosphatidylinositol  and  inositol  phosphate  metabolism 
was specifically associated with ER- and mixed-class hits 
(Fig. 2 C and Fig. S1 B). This is consistent with the notion that 
phosphatidylinositol-modifying kinases may play a role in ER 
export (Blumental-Perry et al., 2006; Farhan et al., 2008).
We also wondered whether our collection of Golgi-class 
hits contains signatures of signaling pathways or cellular pro-
cesses. This issue cannot be addressed with the same approach 
used for the analysis of the ER-class hits because Golgi-class hits 
are associated with only one signaling pathway (Fig. 2 C). This 
difference is explainable by poor hit connectivity, which does not 
allow functional annotation clustering using the DAVID database 
(Fig. 2 B) and thus calls for an alternative approach. We used a 
recently described new way of anchored network construction 
(Yosef et al., 2009). The rationale of this approach is to anchor the 
Golgi-class hits to known proteins involved in Golgi structure 
and biology. We used several anchor proteins. The Golgi matrix 
protein GM130 (GOLGA2) was chosen because of its well   
(Kapetanovich et al., 2005; Palmer et al., 2005; Bejarano et al., 
2006), but detailed understanding of the high-order regulation 
calls for a systematic approach.
Results
Kinases and phosphatases regulating the 
early secretory pathway
To identify genes regulating the ER–Golgi system, we used an 
siRNA-based knockdown approach targeting all human kinases 
and phosphatases for effects on the localization of ERGIC-53, a 
sensitive marker for changes in trafficking and morphology of   
the early secretory pathway (Schweizer et al., 1988; Klumperman   
et al., 1998). The screen was performed in HeLa cells stably ex-
pressing GFP-tagged ERGIC-53 (Ben-Tekaya et al., 2005). Be-
cause of its cycling, the type I transmembrane protein ERGIC-53 
is a sensitive indicator for both changes in bidirectional traffic in 
the secretory pathway and organelle integrity.
Cells were transfected with three siRNAs (not pooled) to 
each of the 916 known and putative protein and lipid kinases and 
phosphatases (724 kinases; 192 phosphatases; Table S1). Trans-
fection efficiency was >80% on average, and down-regulation was 
>70% when tested on various selected proteins. All siRNAs had 
nonoverlapping  sequences.  48  h  after  transfection,  cells  were 
fixed and stained with DAPI/Syto42 to label nuclei and cyto-
plasm, providing information on cell number. Images were ac-
quired by automated spinning disk confocal microscopy. 16 frames/ 
well were acquired for each GFP–ERGIC-53 and DAPI/Syto42. 
Images were analyzed visually. Kinases/phosphatases were cho-
sen for further analysis if two out of three siRNAs affected the   
pattern of ERGIC-53. Kinases/phosphatases were excluded if silenc-
ing either compromised cell viability (i.e., strong reduction in cell 
number) or had previously been reported to induce apoptosis   
in an siRNA screen in HeLa cells (MacKeigan et al., 2005).
Our primary screen retrieved 154 kinases/phosphatases hits.   
To validate them in a secondary screen, endogenous ERGIC-53 
was covisualized with markers for ERESs (Sec31) and Golgi   
(giantin) by double immunofluorescence microscopy. 122 of the 
original 154 hits were validated as true positive (79%; Table S2), 
of which 12% were phosphatases. 56% belonged to one of the 
eight kinase classes (Fig. 1 A). The remainder (32%) belonged 
to the group of atypical, putative, or uncharacterized kinases and 
regulatory subunits. Overall, 8% (16 out of 193) of the phos-
phatome library and 15% (106 out of 723) of the kinome li-
brary were true hits. Importantly, based on screening various 
databases and the literature, we conclude that at least 118 out of 
the 122 identified kinases and phosphatases are expressed in HeLa 
cells (Table S2).
Hits were phenotypically grouped (Fig. 1 B). The ER class 
comprises all hits with enhanced ER staining of ERGIC-53 and 
with reduction of peripheral ERGIC clusters (Fig. 1, compare 
C with D; and Table S2). ERES number was reduced, but the Golgi 
was unchanged. The Golgi class comprises all hits with frag-
mented or tubulated Golgi. Peripheral ERGIC clusters and ERESs 
were unaffected, but juxtanuclear ERGIC was lost (Fig. 1 F and 
Table S2). The overall microtubule organization was unaffected 
(Table S2). The mixed class includes all kinases/phosphatases that 999 MAPK signaling to the early secretory pathway • Farhan et al.
of previous studies was on structural proteins of the Golgi (Rivero 
et al., 2009; Yadav et al., 2009). We asked whether Golgi-class 
hits regulate cell migration. Indeed, in a scratch wound assay, the 
knockdown of various Golgi-class members impaired correct   
position of the Golgi and wound healing (Fig. 4). Thus, besides 
revealing signaling pathways associated with ER hits, our study 
provides a resource of signaling molecules that regulate Golgi 
shape and thereby cell migration.
The MAPK pathway regulates ERESs  
and ER exit
Because  numerous  ER-class  hits  are  members  of  the  MAPK 
pathway, we asked whether the MAPK pathway affects ERESs. 
To determine the range within which ERESs can be regulated in 
our experimental systems, we silenced Sec16, a key regulator of 
ERESs. Knockdown of Sec16 maximally reduces ERES number 
by 50% (Fig. 5 A; Farhan et al., 2008). If the MAPK pathway 
regulates ERESs, its hyperactivation should increase, whereas its 
inhibition should decrease ERES number. This was indeed ob-
served. Silencing NF1 (neurofibromin 1), which hyperactivates 
the MAPK pathway (Fig. S2 A), increased the number of ERESs 
accepted role in Golgi structural maintenance. Moreover, GM130 
was shown to interact with the Golgi-class hit MST4 (Preisinger 
et al., 2004). We also used the cargo receptor p24- (TMED2) 
and the GTPase Arf1. Both proteins play important roles in Golgi 
biology and bidirectional ER to Golgi trafficking. Because the 
Golgi is known to play an important role in cell polarity, we con-
structed a multianchored network with the known polarity regu-
lators Par3 (PARD3), Par6 (PARD6A), PKC- (PRKCZ), Scrib, 
Pals1 (MPP5), and Cdc42 (Fig. 3 A). Four networks were estab-
lished, each of which connected all Golgi-class hits. The four 
networks were then merged by generating a union using the Cyto-
scape software and analyzed using the BiNGO plugin (Fig. 3 A). 
BiNGO detects specific enrichment of Gene Ontology (GO) an-
notations for cellular processes. To test for the enrichment of sig-
naling  pathways,  we  analyzed  the  merged  network  using  the 
DAVID database. Several signaling pathways and cellular pro-
cesses were enriched (Fig. S1 C). By combining the BiNGO and 
DAVID analyses, we note possible links between Golgi structure 
and apoptosis, proliferation, cell size, and infection. Golgi posi-
tioning was previously shown to also play an important role in di-
rectional cell migration (Yadav et al., 2009). However, the focus 
Figure 1.  Classification of kinase/phosphatase hits. (A) Assignment to protein families. TKL, Tyr kinase–like; STE, related to sterile kinases; CK1, casein 
kinase 1; AGC, kinase family containing PKA, PKG, and PKC; CAM kinase, calmodulin kinases; CMGC, kinase family containing CDK, MAPK, GSK, 
and CKL. (B) Phenotypic classification of hits. (C–F) Immunofluorescence of phenotypes. HeLa cells transfected with control siRNA (C) or siRNA to MAPK4 
(example of the ER class; D), SCYL1 (example for the mixed class; E), and MAPK14 (example for the Golgi class; F) are shown. Cells were fixed 72 h after 
transfection and double stained with antibodies against the indicated proteins. Bars, 10 µm.JCB • VOLUME 189 • NUMBER 6 • 2010   1000
Figure 2.  Network of kinase hits indicates a role for MAPK signaling in the regulation of ER export. (A) All ER-class hits were assembled into a network 
using the STRING database. (B) Assembly of all of the Golgi-class hits into a network using the STRING database. Edges in both networks indicate an 
interaction that is experimentally verified or an association into a signaling pathway. (C) ER-, mixed-, and Golgi-class hits specifically enriched in signaling 
pathways deduced from the DAVID database.
by 20% (Fig. 5 A). In contrast, silencing ERK2 (an ER-class hit) 
but not ERK1 significantly reduced the number of ERESs by 
30% (Fig. 5 A). Thus, the full range by which the MAPK 
pathway can regulate ERES number is 50%. Knockdown of 
ERK2 did not affect the levels of ERK1 (Fig. 5 B), indicating that 
the effect of ERK2 silencing was specific. To further support this, 1001 MAPK signaling to the early secretory pathway • Farhan et al.
Figure 3.  BiNGO analysis of Golgi-class hits from four anchored networks. (A) Four networks were generated with the Golgi-class hits anchored to 
GOLGA2, TMED2, ARF1, and polarity regulators (Par3, Par6, Cdc42, Pasl1, PKC-, and Scrib). Networks were merged using the Cytoscape software and 
analyzed using the BiNGO 2.3 plugin. GO term cellular processes were scored at a significance value of at least 0.001. The Benjamini-Hochberg false 
discovery rate correction was used. (B) The network of cellular processes displayed in a hierarchical layout. Large PDF versions of these networks and their 
underlying data (which can be opened and visualized in Cytoscape) can be found in the online supplemental material.
we performed rescue experiments with Flag-tagged rat ERK2, 
which is not recognized by the siRNA to human ERK2. Cells were 
transfected with control or ERK2 siRNA and processed for ERES 
analysis 72 h later. In the rescue experiment, the Flag-tagged rat 
ERK2 cDNA was transfected 24 h before ERES analysis. Fig. 5 C 
shows that the Flag-tagged rat ERK2 can reincrease the number   JCB • VOLUME 189 • NUMBER 6 • 2010   1002
the response curve to mitogens (Fig. S2 B). As expected for a 
scaffold, overexpression of HA-tagged CNK1 also had a negative 
effect and thus reduced ERES number (Fig. 5 A). Collectively, 
these results show that the Raf–MEK (MAPK/ERK [extracellu-
lar signal-regulated kinase] kinase)–ERK pathway, via ERK2, 
regulates the number of ERESs and ER to Golgi transport.
ERK2 stimulates COPII vesicle budding
Does ERK2 affect the biogenesis of transport vesicles? We used 
an established in vitro COPII vesicle budding assay to address 
this question (Kim et al., 2005). HeLa microsomes were incu-
bated with ERK2-depleted HeLa cytosol, ATP-regenerating   
system, and GTP for 30 min at 25°C, and the appearance of   
ERGIC-53 in the vesicle fraction was monitored. The addition of 
purified ERK2 to the reaction mixture increased the amount of 
ERGIC-53 in the vesicle fraction (Fig. 6), indicating that ERK2 
stimulates the formation of COPII vesicles at the ER. Our bud-
ding assay truly measures COPII vesicle production because de-
pletion of Sec24A+B from the cytosol affected incorporation of 
of ERESs, very much in contrast to a kinase-dead version of 
ERK2 (ERK2-K52R).
Next we tested whether the decrease in the number of   
ERESs translates into an effect on ER to Golgi transport. Silencing 
of ERK2 indeed reduced ER to Golgi transport of endogenous 
transferrin receptor in HeLa cells (Fig. 5 D). Because ERGIC-53   
was used as a readout in our screen, we also tested transport   
of  the  ERGIC-53  cargo  protein  1-antitrypsin.  Inhibition   
of  the  MAPK  pathway  by  PD98059  reduced  transport  of   
1-antitrypsin (Fig. 5 E).
The  MAPK  pathway  is  regulated  by  scaffolds  (Kolch, 
2005). Our library included the CNK1 (connector enhancer of the 
kinase suppressor of Ras-1) and the kinase suppressor of Ras-1 
and -2. In addition, MEKK1 is also thought to act as a scaffold 
(Karandikar et al., 2000). In our screen, CNK1 and MEKK1 were 
ER-class hits. Knockdown of CNK1 (Fig. 5 A) and MEKK1 (not 
depicted) reduced the number of ERESs. The effect of CNK1 was 
weak, but this was to be expected because CNK1 knockdown 
does not completely block the MAPK pathway but rather flattens 
Figure 4.  Kinases and phosphatases of the Golgi class inhibit orientation of the Golgi toward a scratch wound. HeLa cells were transfected with siRNAs to 
the indicated genes. After 72 h, a scratch wound was introduced. 6 h later, cells were fixed and stained for giantin to label the Golgi. (A) Representative 
images. (B) Quantification of two experiments with at least 35 cells each displayed as the percentage of cells exhibiting Golgi orientation to and away 
from the wound. (C) 48 h after the indicated knockdown, a wound was introduced, and cells were fixed 24 after later. Cells were labeled with FITC-tagged 
Con A. Note that STYX and AKAP28 knockdown cells fail to close the wound, in contrast to control cells. (A and C) White lines indicate the position of the 
scratch. Bars: (A) 10 µm; (C) 200 µm.1003 MAPK signaling to the early secretory pathway • Farhan et al.
ERGIC-53 into vesicles (Fig. S3). We showed previously that ER 
export of ERGIC-53 is dependent on these Sec24 isoforms   
(Wendeler et al., 2007).
Sec16 is a target of the Raf–MEK–ERK 
signaling pathway
Sec16 is a key regulator of ERES biogenesis and maintenance, 
making it a prime candidate for an ERK2 target. We first assessed 
whether the MAPK pathway affects the in vivo dynamics of 
Sec16. This is best probed by FRAP of individual ERESs labeled 
by GFP-tagged Sec16. As shown in Fig. 7 A, GFP-Sec16   
(National Center for Biotechnology Information Protein acces-
sion number O15027) nicely recovered after photobleaching of 
control cells as opposed to ERK2-silenced cells or cells in which 
the MAPK pathway was pharmacologically blocked. This is also 
illustrated by the significantly higher mobile fraction of Sec16 
under control conditions (Fig. 7 B). In addition, we compared 
fluorescence recovery in serum-starved cells and cells treated 
with EGF (for 10 min). Treatment with EGF enhanced fluores-
cence recovery of Sec16 (Fig. 7 C) and increased the mobile frac-
tion of Sec16 (Fig. 7 D). The change in mobility of Sec16 also 
translated into a change in the mobility of downstream COPII 
components. Treatment with EGF increased the recovery and 
mobile fraction of YFP-tagged Sec24D (Fig. 7, E and F). Because 
Sec16 responds to alterations of the MAPK pathway, it is a likely 
ERK2 target.
We monitored whether Sec16 is phosphorylated on a Ser/
Thr-Pro sequence using a MAPK substrate antibody. This would 
be expected if Sec16 was an ERK target. GFP-Sec16 was immuno-
precipitated, subjected to SDS-PAGE, and immunoblotted with 
antibodies to Sec16. The blots were stripped and reprobed with 
antibodies  to  a  phosphorylated  MAPK  substrate.  If  Sec16  is 
phosphorylated on a MAPK target sequence, a band should ap-
pear at the same position as the Sec16 band before stripping. This 
was indeed observed. Fig. 8 A shows that Sec16 was phosphory-
lated on a MAPK target sequence, and this phosphorylation   
diminished when cells were cultured in the absence of mitogens 
(that is, in serum-free medium). Because Sec24D also responded 
to EGF treatment in our FRAP assay, we tested whether Sec24D 
is also recognized by the MAPK substrate antibody. However, 
this was not the case (unpublished data). This result indicates that 
the change in the mobility of Sec24D is not caused by phosphory-
lation by the MAPK pathway. Most likely, the increase of Sec24D 
mobility is indirectly induced by Sec16.
To more directly test whether Sec16 is phosphorylated by 
ERK, we performed in vitro experiments. Fig. 8 B shows that   
immunoisolated GFP-Sec16 from serum-starved cells, which are 
Figure 5.  A role for MAPK signaling in the regulation of ERES number and 
ER to Golgi transport. (A) HeLa cells were transfected with the indicated 
siRNAs and fixed after 72 h. Anti-Sec31–labeled ERESs were quantified 
(means ± SD; n = 3). Asterisks indicate statistically significant differences 
(*, P < 0.05) from control (unpaired t test). (B) Cells were transfected with 
control or ERK2 siRNA. After 72 h, cells were lysed, and ERK1/2 was 
detected by immunoblotting. (C) HeLa cells were transfected with control 
or ERK2 siRNA (siERK2). After 48 h, the ERK2 siRNA–treated cells were 
left untreated (mock) or were transfected with Flag-tagged ERK2 cDNA or 
Flag-tagged ERK2-K52R cDNA. Cells were fixed 24 h later and stained for 
Flag and Sec31, and ERESs were counted. Asterisks indicate statistically 
significant differences (*, P < 0.05). (D) ER–Golgi transport of endogenous 
transferrin receptor was measured 72 h after transfection with the indicated 
siRNAs. Cells were subjected to pulse-chase experiments with [
35S]Met.   
Transferrin receptor was immunoprecipitated, treated with Endo H, sepa-
rated by SDS-PAGE, and visualized by autoradiography. C0 and C30: con-
trol siRNA transfected and chased for 0 min and 30 min, respectively. 
ERK2: knockdown cells chased for 30 min. The bar diagram shows   
means ± SD (n = 3). The asterisk indicates statistically significant difference 
(*, P < 0.05) from control (unpaired t test). (E) ER–Golgi transport of endog-
enous 1-antitrypsin in HepG2 cells. 2 d after plating, cells were subjected 
to pulse-chase experiments with [
35S]Met. Cells were treated with DMSO 
(C) or the MEK inhibitor PD98059 (+PD) for 30 min before the pulse. Cells 
were pulsed for 10 min and chased for 15 min. C0 and C15: DMSO-
treated cells chased for 0 min and 15 min, respectively. +PD: PD98059-
treated cells chased for 15 min. The bar diagram is an evaluation of two 
independent experiments. (B, D, and E) The black lines on the blot indicate 
the position of the 50-kD (B and E) or 75-kD (D) molecular mass marker.
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This conclusion is supported by the finding that, at steady-state, 
Sec16-T415I exhibited some remaining phosphorylation (10–30% 
of Sec16-WT) when immunoprecipitated from HeLa cells 
(Fig. 8 H). Like Sec16-923, Sec16-T415I did not respond to 
EGF treatment in the FRAP experiment (Fig. 8, I and J), sup-
porting the notion that T415 is an important site for the regulation 
of Sec16 by ERK signaling.
Next, we asked whether the mutation of Thr415 to Ile af-
fects the number of ERESs. To this end, we overexpressed either 
GFP-tagged wild-type Sec16 (Fig. 9 A) or GFP-tagged Sec16-
T415I (Fig. 9 B). After 24 h, ERESs were stained for Sec31 and 
quantified. We also determined the effect of the mutation on pe-
ripheral ERGIC structures by staining for ERGIC-53. Exogenous 
expression of Sec16 exerts a negative effect on ERESs if the level 
of expression is too high. Therefore, we compared cells with only 
moderate GFP (i.e., Sec16) levels. In addition, we only compared 
cells with similar expression levels of GFP-Sec16 constructs. For 
quantification, we determined the value of GFP fluorescence and 
normalized it by the area. The mean fluorescence values (in arbi-
trary units) of cells expressing GFP–ERGIC-53 and GFP–
Sec16-T415I were 3.48 ± 1.08 and 3.57 ± 1.46, respectively 
(means ± SD; three independent experiments). Expression of 
GFP–Sec16-T415I reduced the number of both ERESs and 
peripheral ERGIC punctae (Fig. 9 C). Furthermore, ERGIC-53 
exhibited a stronger ER pattern in cells expressing the mutant 
Sec16, reminiscent of the ER-class hits (Fig. 9 B). The degree of 
down-regulation of ERESs was comparable with that observed in 
ERK2 knockdown cells (Fig. 5 A).
If Sec16 is a target of the MAPK pathway, its hyperactiva-
tion should increase the level of Sec16 phosphorylation. Such a 
hyperactivation can be achieved by expression of a constitutively 
active form of Ras (RasV12). We coexpressed GFP-Sec16 either 
with wild-type Ras or RasV12 linked to the ER (M1-RasV12). 
The ER version of RasV12 was previously shown to be a strong 
stimulator of the Raf–MEK–ERK pathway and cell growth   
(Matallanas et al., 2006). Sec16 phosphorylation was more than 
twofold higher in cells expressing RasV12 than in cells express-
ing wild-type Ras (Fig. 9 D). In addition, RasV12-expressing 
cells had a higher number of ERESs (Fig. 9 E), thereby linking 
Sec16 phosphorylation to ERES number. We conclude that Sec16 
is a new target of ERK2.
Discussion
Genetic and biochemical analyses over the past three decades 
have provided profound understanding of the machineries medi-
ating bidirectional ER–Golgi trafficking (Rothman and Wieland, 
1996; Bonifacino and Glick, 2004; Lee et al., 2004), and consid-
erable knowledge is available on organelle shape and proteomics 
(Gilchrist et al., 2006; Gillingham and Munro, 2007; Cai et al., 
2007). What has almost entirely been lacking is an understanding 
of high-order regulation of the secretory pathway by cellular sig-
naling pathways. A recent study reported that arrival of a cargo 
wave in the Golgi activates Src family kinases (Pulvirenti et al., 
2008). Although this is an example for an adaptive response, it 
does not address the regulation of the secretory pathway by sig-
naling under basal conditions.
not phosphorylated, can be phosphorylated by incubation with 
immunoprecipitated active ERK (Fig. 8 B). To exclude that Sec16 
was phosphorylated by a nonspecific component in the phospho-
ERK immunoprecipitate, we performed experiments with recom-
binant ERK2. Recombinant active ERK2 also phosphorylated 
Sec16 (Fig. 8 C). Of note, both immunoprecipitated phospho-
ERK and recombinant active ERK2 were active under our assay 
conditions as they were able to phosphorylate Elk1, a well known 
ERK target (Fig. 8 D).
In a next series of experiments, we attempted to identify the 
phosphorylation site or sites in Sec16 targeted by ERK2. A Sec16 
mutant lacking the first 923 aa (Sec16-923) still correctly local-
izes to ERESs (Bhattacharyya and Glick, 2007). This offers the 
possibility to test whether the phosphorylation site is located 
within the first 923 aa of Sec16. Sec16-923 was not phosphory-
lated by ERK2 (Fig. 8 E) and, unlike wild-type Sec16, its mobil-
ity on ERESs did not respond to EGF treatment in the FRAP 
experiment (Fig. 8, E and F). This indicates that the phosphoryla-
tion site is likely located within the N-terminal 923 residues. 
Searching the amino acid sequence by Scansite (http://scansite 
.mit.edu/) revealed T415 as the most probable ERK target. We 
mutated T415 to Ile (Sec16-T415I), which reduced the ability of 
recombinant active ERK2 to phosphorylate Sec16 by at least 
60% (Fig. 8 C), without affecting Sec16 localization (not de-
picted). The residual signal is most likely caused by minor phos-
phorylation of other residues by ERK2 in vitro (according to 
Scansite,  there  are  27  theoretical  Pro-dependent  Ser  or  Thr   
sites in Sec16, 14 of which are within the N-terminal 923 aa). 
Figure 6.  ERK2 stimulates COPII vesicle budding. HeLa microsomes were 
incubated for 30 min with ATP and an ATP-regenerating system, GTP, and 
cytosol of ERK2-silenced HeLa cells in the presence or absence of purified 
ERK2. COPII vesicles (V) were collected by centrifugation and immunoblot-
ted for anti–ERGIC-53 and anti–CLIMP-63 (ER marker). The asterisk repre-
sents a statistically significant difference (*, P < 0.05; paired t test). Error 
bars indicate ±SD. M, 33% microsome input.1005 MAPK signaling to the early secretory pathway • Farhan et al.
of the MAPK pathway increases, and its inhibition decreases 
ERES number. The range within which the ERES number was 
regulated by the MAPK pathway was 50%. Because this number 
is based on knockdown and not knockout conditions, the actual 
range in the cell may be even bigger.
A full-genome screen for regulators of secretion in Dro-
sophila melanogaster cells revealed 130 hits (Bard et al., 2006). 
Our  siRNA  screen  provides  a  global  view  of  kinase/
phosphatase signaling to the early secretory pathway. Our key 
findings are as follows: (a) at least 122 kinases and phosphatases 
control the organization and/or traffic of the ER–Golgi system; 
(b) the Raf–MEK–ERK pathway controls ERES formation, COPII 
vesicle budding, and ER to Golgi transport; and (c) the ERES   
protein Sec16 is a target of the ERK2 pathway. Hyperactivation   
Figure 7.  Changes in Sec16 dynamics upon inhibition or activation of the MAPK pathway. (A) Cells were transfected with control siRNA or siRNA to ERK2. 
After 48 h, cells were transfected with GFP-Sec16 cDNA, and 24 h later, FRAP analysis was performed. Of the two control siRNA–transfected cells, one 
dish was treated with solvent (control) and one with the MEK inhibitor PD98059 for 30 min before analysis. The right panel shows examples of bleached 
ERESs with indicated time points. (B) Quantification of mobile fractions from the curves in A (see Materials and methods). Asterisks indicate statistically 
significant differences (means ± SD; three independent experiments; *, P < 0.01; unpaired t test). (C) HeLa cells expressing GFP-Sec16 were serum starved 
for 8 h before the FRAP experiment (WT-ut). Afterward, cells were treated with EGF for 10 min, and further FRAP curves were recorded from the same dish 
(WT+EGF). (D) Quantification of mobile fractions from the curves in C (see Materials and methods; means ± SD; three independent experiments, four curves 
each; paired t test). (E) HeLa cells expressing YFP-Sec24D were serum starved for 8 h before the FRAP experiment (Sec24D-ut). Afterward, cells were treated 
with EGF for 10 min, and additional FRAP curves were recorded from the same dish (Sec24D+EGF). (F) Quantification of mobile fractions from the curves 
in E (see Materials and methods; means ± SD; three independent experiments, four curves each; paired t test). Bar, 1 µm.JCB • VOLUME 189 • NUMBER 6 • 2010   1006
Figure 8.  Sec16 is a target of the MAPK pathway. (A) Cells were transfected with GFP-Sec16 cDNA. After 8 h, medium was replaced by complete medium 
(Cont) or medium without serum (starved). Sec16 was immunoprecipitated with anti-GFP, subjected to SDS-PAGE, and immunoblotted with anti-Sec16 (top). 
The blot was stripped and reprobed with anti–MAPK substrate (bottom). The numbers above the blot indicate relative amounts determined by densitometric 
scanning. The intensity of the MAPK substrate band was normalized to the Sec16 band. To facilitate comparisons, the value of the control band was set to 1.   
Note that starvation reduces phosphorylation of Sec16 by 40% (means ± SD; three independent experiments; P < 0.05). (B) Cells were transfected with 
GFP-Sec16 and, after 8 h, serum starved. Sec16 was immunoprecipitated with anti-GFP. A parallel cell culture was treated with EGF. Active ERK was   
immunoprecipitated with agarose-coupled anti–phospho-ERK and incubated with the immunoprecipitated active ERK. Immunoprecipitated GFP-Sec16 and 
immunoprecipitated phospho-ERK were mixed, and the kinase reaction was performed for 30 min at 30°C (reaction). 50% of the reaction was separated by 
SDS-PAGE and immunoblotted with anti-Sec16 (top). The blot was stripped and reprobed with anti–MAPK substrate (bottom). (C) Cells were transfected with 
GFP-Sec16 cDNA (wild type [wt] or T415I). Immunoprecipitated Sec16 (anti-GFP) was coincubated with active ERK2 and ATP for 30 min at 30°C. 50% of 
the reaction was loaded, subjected to SDS-PAGE, and immunoblotted with anti-Sec16 (top). The blot was stripped and reprobed with anti–MAPK substrate 
antibody (bottom). The numbers above the blot indicate relative amounts determined by densitometric scanning. The intensity of the MAPK substrate band 
was normalized to the Sec16 band. To facilitate comparisons, the value of the control band was set to 1. Note that the mutation of T415I reduces the 
ability of ERK2 to phosphorylate Sec16 by at least 65% (means ± SD; three independent experiments). (D) Phosphorylation of purified GST-tagged Elk1 
by immunoprecipitated phospho-ERK1/2 (IP p-ERK) as described in B or recombinant active ERK2 (rec. ERK2). The reaction was performed at 30°C for 
30 min either with buffer () or with the kinase (+). (E) HeLa cells were transfected with a plasmid encoding GFP-Sec16 lacking the N-terminal 923 aa.   
Sec16 was immunoprecipitated with anti-GFP and incubated with active ERK2 and ATP for 30 min at 30°C. Samples were subjected to SDS-PAGE and 
immunoblotting with anti-Sec16 (top). The blot was stripped and reprobed with anti–MAPK substrate antibody (bottom). The arrow indicates the position 1007 MAPK signaling to the early secretory pathway • Farhan et al.
and the EGF receptor, were retrieved as ER-class hits. We did 
not find MEK1 and -2 in our screen, most likely because of   
redundant signaling at this level of the MAPK pathway. The   
human kinome contains 20 kinases at the level of MAPK kinase 
kinase (MAP3K1–14, Raf1, A-Raf, B-Raf, and TAO kinases 1–3) 
and 14 at the level of MAPK (MAPK1 and MAPK3–15).   
However, there are only seven kinases at the level of MAPK   
kinase (MAP2K1–7). This fact points to a high degree of redun-
dancy between different MAPK kinases. MEK1 and -2 share 
85% sequence identity. Their abilities to phosphorylate ERK1 
and -2 are similar, and individual deletion of MEK1 or -2 in skin 
fibroblasts does not reduce the amount of active ERK1/2 (Scholl 
et al., 2007). To the contrary, a single deletion of MEK1 seems 
to increase the level of active ERK1/2 (Catalanotti et al., 2009). 
In view of these considerations, it is not surprising that we did 
not hit MEK1/2.
We provide evidence that the effect of ERK2 on ERESs is 
mediated by Sec16, a major regulator of ERES homeostasis. 
Sec16 was directly phosphorylated by immunoprecipitated 
ERK and by recombinant active ERK2, most likely on T415. 
This residue was found to be phosphorylated in vivo (Olsen   
et al., 2006). Expression of a constitutively active Ras version 
resulted in an increase in Sec16 phosphorylation and in an in-
crease in ERES number. This finding links the phosphorylation 
of Sec16 to the number of ERESs. Our combined data suggest 
the signaling model illustrated in Fig. 10. Although important, 
ERK2 may not be the only regulator of Sec16. According to the 
Phosida database (http://www.phosida.com), there are 49 sites 
in Sec16 that are phosphorylated, but their functional relevance 
is unknown. Moreover, it is worth noting that the ERES local-
ization of Sec16 is determined by a sequence of basic amino   
acids in the central conserved domain of the protein (Ivan et al., 
2008). The role of ERK2 is to modulate this localization in a 
dynamic way. Because growth factor signaling increases pro-
tein synthesis, we speculate that ERK2 adjusts ERESs to cope 
with this condition. In addition, environmental changes (e.g., 
nutrients and mitogens) can be sensed and this information 
transmitted via the MAPK pathway to instruct ERESs to change 
the rate of cargo flux.
Alterations of the MAPK pathway may indirectly affect 
ERES number by changing the translation rate and thereby 
cargo load. Although we cannot entirely rule out this possibility, 
the following considerations argue for a direct effect. First, 
pharmacological inhibition of the MAPK pathway (by PD98054 
for 30 min) reduced ER to Golgi transport of 1-antitrypsin 
The comparatively high number of kinases/phosphatases (122) 
affecting the early secretory pathway in our screen appears sur-
prising at first sight. This difference is largely caused by the fact 
that the Drosophila screen monitored secretion of a soluble pro-
tein rather than morphological changes of the secretory pathway. 
Most of our kinase hits are specific to the early secretory path-
way as they overlap with only 12% of hits from a screen for   
kinases affecting clathrin- and caveolae-mediated endocytosis 
(Table S2; Pelkmans et al., 2005).
Signaling  involved  in  mitotic  Golgi  fragmentation  has 
been elucidated in quite some detail (Colanzi et al., 2003). In 
contrast, the role of signaling in Golgi structure regulation dur-
ing interphase remains largely unknown. Mitotic Golgi frag-
mentation depends on signaling via MEK and ERK (Shaul and 
Seger, 2006; Feinstein and Linstedt, 2008). A recent study 
shows that MEK to ERK signaling to the Golgi does not involve 
the classical MEK1/2 to ERK1/2 route. Mitotic Golgi fragmen-
tation was mediated by a splice variant of MEK1, MEK1b, 
which activates a splice variant of ERK1 termed ERK1c (Shaul 
et al., 2009). Consistent with this observation, we have no indi-
cation for a role of ERK signaling to the Golgi in interphase 
cells, as treatment with EGF did not fragment the Golgi (unpub-
lished data).
An RNAi screen was recently performed to find regulators 
of cell migration (Simpson et al., 2008). The library targeted 
1,081 human genes encoding phosphatases, kinases, and pro-
teins predicted to influence cell migration and adhesion. The 
screen identified 79 high and medium confidence genes that im-
paired cell migration. Because we propose that our Golgi-class 
hits regulate cell migration, we expected to find a considerable 
overlap. However, this was not the case. The only gene common 
to both studies is CDK4, which we found to inhibit Golgi orien-
tation in the wound-healing assay (Fig. 4 B). However, the 
screen of Simpson et al. (2008) failed to retrieve kinases known 
to regulate cell migration such as MAPK9, -10, and -14, which 
appeared as Golgi-class hits in our screen. These hits indicate 
that our collection of kinases/phosphatases required for main-
taining Golgi structure is a promising resource for future studies 
on Golgi ribbon maintenance and its role in directional cell mi-
gration as well as in the cellular processes shown in Fig. 3 B.
How growth factors signal to the secretory pathway has 
been unknown. In this study, we show that growth factors signal 
to  ERESs  via  the  Raf–MEK–ERK  pathway  in  an  ERK2- 
dependent manner. Besides ERK2, upstream activators and posi-
tive modulators of ERK2, including Raf1, A-Raf, CNK1, MEKK1, 
where a band would be expected in case of corresponding phosphorylation. (F) HeLa cells expressing GFP-tagged truncation mutant of Sec16 lacking the 
N-terminal 923 aa (delta) were serum starved for 8 h before the FRAP experiment (delta-ut). Afterward, cells were treated with EGF for 10 min, and further 
FRAP curves were recorded from the same dish (delta+EGF). (G) Quantification of the mobile fractions from the curves in F (see Materials and methods; 
means ± SD; three independent experiments). (H) Cells were transfected with GFP-Sec16 cDNA (wild type [wt] or T415I). Sec16 was immunoprecipitated 
with anti-GFP, subjected to SDS-PAGE, and immunoblotted with anti-Sec16 (top). The blot was stripped and reprobed with anti–MAPK substrate (bottom). 
The numbers above the blot indicate relative amounts determined by densitometric scanning. The intensity of the MAPK substrate band was normalized to 
the Sec16 band. To facilitate comparisons, the value of the control band was set to 1. Note that the T415I mutation reduces the phosphorylation of Sec16 
down to 30% (means ± SD; four independent experiments). (I) HeLa cells expressing GFP-tagged Sec16-T415I were serum starved for 8 h before the FRAP 
experiment (T415I-ut). Thereafter, the cells were treated with EGF for 10 min, and additional FRAP curves were recorded from the same dish (T415I+EGF). 
(J) Quantification of the mobile fractions from the curves in I (see Materials and methods; means ± SD; three independent experiments). (A–E and H) Black 
lines on the blots indicate the position of the 250-kD (A–C), 50-kD (D), 150-kD (E), or 250-kD (H) molecular mass marker.
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levels. They display increased levels of basal ERK2 phosphory-
lation and thus activity (Agrawal et al., 2006). We speculate that 
stimulation  of  immunoglobulin  secretion  is,  at  least  in  part, 
caused by augmented ERK2 levels. Another example is the   
antibody-mediated autoimmune disease systemic lupus erythe-
matosus (SLE). Both in a mouse model of SLE and in a subset 
of SLE patients, a point mutation in the receptor leukocyte Tyr 
kinase (LTK) was identified that renders this enzyme hyperactive 
(Li et al., 2004). LTK is one of our ER-class hits, and its silenc-
ing strongly reduced the number of ERESs and ER to Golgi 
transport (unpublished data). It is tempting to speculate that 
LTK has a direct regulatory role in immunoglobulin secretion.
In conclusion, our study provides not only a resource of 
signaling molecules involved in the regulation of morphology 
(Fig. 5 E). Second, ERK2 directly stimulated COPII vesicle 
budding in vitro (Fig. 6). Third, pharmacological inhibition of 
the MAPK pathway (by PD98054 for 30 min) altered Sec16 
dynamics on ERESs (Fig. 7 A). Fourth, NF1 knockdown, which 
hyperactivates the Raf–MEK–ERK pathway, did not induce ER 
stress (unpublished data). Stress induction would be expected if 
the increase in ERES number was a result of cargo overload 
(Farhan et al., 2008).
Our discovery of a link between the MAPK pathway and 
ER export provides a framework for a better mechanistic under-
standing of diseases associated with alterations of secretion.   
A case in point is hypersecretion of immunoglobulins observed 
in autoimmune disorders. ERK1 knockout mice are more prone 
to autoimmunity and have 10-fold higher plasma immunoglobulin 
Figure 9.  Phosphorylation of Sec16 is linked to 
ERES number. (A–C) Hells cells were transfected 
with  cDNA  encoding  wild-type  GFP-Sec16 
(GFP–Sec16-wt;  A)  or  GFP–Sec16-T415I  (B), 
fixed 24 h later, and immunostained for Sec31 
to label ERESs or ERGIC-53 to label the ERGIC. 
(C) The number of ERESs and peripheral ERGIC 
punctae was counted. The bar graph represents 
the number of punctae positive for Sec31 (ERES) 
or ERGIC-53 (ERGIC). The values determined in 
cells expressing GFP–Sec16-wt were set to 100% 
(means  ±  SD;  three  independent  experiments; 
asterisks  indicate  statistically  significant  differ-
ence to GFP–Sec16-wt; *, P < 0.05; unpaired 
t test). (D) Cells were transfected with cDNA for 
GFP-Sec16 together with either wild-type H-Ras 
(Ras-wt) or M1–H-RasV12 (RasV12). Sec16 was 
immunoprecipitated with anti-GFP, subjected to 
SDS-PAGE, and immunoblotted with anti-Sec16 
(top). The blot was stripped and reprobed with 
anti–MAPK  substrate  (bottom).  The  numbers 
above the blot indicate relative amounts deter-
mined by densitometric scanning. The intensity 
of  the  MAPK  substrate  band  was  normalized 
to the Sec16 band. To facilitate comparisons, 
the mean value of the samples transfected with 
wild-type Ras was set to one (mean ± SD; three 
independent experiments). The black line on the 
blot indicates the position of the 250-kD molecu-
lar mass marker. (E) Cells were transfected with 
cDNA for HA-tagged M1-RasV12. After 24 h, 
cells were fixed and costained for HA (RasV12) 
and  Sec31.  The  bar  graph  shows  ERESs/cell 
comparing  cells  expressing  RasV12  or  not 
(control; means ± SD; three independent experi-
ments; asterisk indicates statistically significant 
difference; *, P < 0.05 from control; unpaired 
t test). Bars, 10 µm.1009 MAPK signaling to the early secretory pathway • Farhan et al.
Antibodies and immunofluorescence microscopy
Monoclonal antibodies to ERGIC-53 (Schweizer et al., 1988), Sec31 (BD), 
and GFP (Roche) were used. Rabbit antibodies to giantin (gift of A. Linstedt, 
Carnegie Mellon University, Pittsburgh, PA), Sec24A and -B (gift of J.-P. 
Paccaud,  Drugs  for  Neglected  Diseases  Initiative,  Geneva,  Switzerland), 
Sec31 (gift of F. Gorelick, Yale University, New Haven, CT; Shugrue et al., 
1999), ERK1/2, phosphorylated ERK1/2, MAPK substrate, PKC substrate 
(Cell Signaling Technology), Sec16 (Iinuma et al. 2007), Sec24D (Wendeler 
et al., 2007), and XBP1s (BioLegend) were also used. FITC–Con A was ob-
tained from Invitrogen. HeLa cells were fixed with 3% paraformaldehyde, 
pH 7.4, for 30 min at room temperature, permeabilized for 4 min with PBS 
supplemented with 20 mM Gly, 0.2% Triton X-100, and 3% bovine serum 
albumin, and stained with antibodies. Images were acquired with a confo-
cal microscope (SPE; Leica) using a 40× oil objective. For counting periph-
eral ERGIC clusters and ERESs, images were acquired with an additional 
1.5 magnification in one confocal plane with a thickness of typically 210 nm.   
The raw images were converted to TIF files and analyzed using ImagePro 
Plus software (Media Cybernetics). Anti-Sec31–labeled ERESs were defined 
as bright objects in the top 80% of the intensity scale with a diameter of 
>1.5 pixels. This evaluation allows exclusion of objects that are too dim and 
too small and thereby avoids counting false objects that may occur as the 
result of the pixelization of images. Alternatively, ERESs were counted using 
ImageJ. Here, all circular objects were analyzed. The threshold was set in-
dividually for every image to assure that only true ERESs were counted. Both 
methods produced very similar results. For the counting of ERESs, 25–84 
cells were evaluated per condition, and three independent experiments were 
performed. In experiments dealing with transfected GFP-Sec16, we only 
chose moderately expressing cells. Here, we used 10–19 cells per condi-
tion in three independent experiments.
Pulse-chase experiments
HeLa cells (2 × 10
5 in 2.5-cm dishes) were transfected with 5 nM siRNA. 
Pulse-chase  experiments  were  performed  72  h  after  transfection.  Cells 
were incubated in Met-free DME (supplemented with Gln and dialyzed 
FBS) for 20 min and pulsed in medium containing [
35S]Met (100 µCi/dish) 
for 10 min. The medium was then replaced by complete DME containing 
10 mM nonlabeled Met. Cells were lysed after different chase times and 
subjected to immunoprecipitation.
Vesicle budding assay
The following buffers were used: buffer E (50 mM Hepes-KOH, pH 7.2, 
250 mM sorbitol, 70 mM KOAc, 5 mM EDTA, and 0.5 mM MgOAc), 
buffer F (10 mM Hepes-KOH, pH 7.2, 250 mM sorbitol, 10 mM KOAc, 
and function of the secretory pathway but also uncovers growth 
factor signaling to ERESs via ERK2. The latter finding expands 
the already complex repertoire of cellular functions of ERKs and 
may have implications for understanding various disease states 
involving the MAPK pathway, including autoimmunity, cancer, 
and RAS/MAPK syndromes.
Materials and methods
High-throughput siRNA screening
The  procedure  was  performed  essentially  as  described  previously   
(Pelkmans  et  al.,  2005).  In  brief,  HeLa  cells  (1,000  per  well)  were 
seeded into 384-well plates and transfected 24 h later with 20 µM 
siRNA complexed with INTERFERin (Polyplus Transfection) as delivery 
agent. After 48 h, cells were fixed and labeled with 3.7% paraformaldehyde.   
Images were acquired using the Opera automated spinning disk confocal 
microscope (PerkinElmer).
FRAP microscopy
HeLa cells expressing GFP-tagged Sec16 (Addgene) or YFP-tagged Sec24D 
(gift from R. Pepperkok, European Molecular Biology Laboratory, Heidel-
berg, Germany) were cultured on glass coverslips, transferred to imaging 
medium 1 (Ham’s F12 supplemented with 20 mM Hepes, pH 7.4) in a   
Ludin chamber (Life Imaging Services GmbH), and imaged with a 63× oil 
objective on a microscope (SP5; Leica) at room temperature. All FRAP ex-
periments were performed by bleaching individual ERESs. A prebleaching 
scan was performed, and the area of interest was subsequently bleached 
at full laser power for 1.4 s. Pictures were taken every 1.4 s for 56 s, con-
verted to TIF files, and analyzed using ImageJ 1.4g (National Institutes of 
Health). Fluorescence values of the region of interest were normalized to 
prebleaching values. The mobile fraction was calculated according to Reits 
and Neefjes (2001) following the equation R = (F  F0)/(Fi  F0), where 
F is fluorescence in the bleached region after recovery, Fi is the fluores-
cence in the bleached region before bleaching, and F0 is the fluorescence 
in the bleached region directly after bleaching.
Cell culture and transfection
HeLa cells were cultured in DME containing 10% FBS and antibiotics. For 
gene silencing, cells cultured in 6-well plates were transfected with 5 nM 
siRNA using HiPerFect (QIAGEN) and typically analyzed after 72 h. cDNA 
transfection was performed using FuGene6 (Roche) 24 h before analysis.
Figure 10.  Model of the pathway signaling 
to ERESs. EGFR, EGF receptor.JCB • VOLUME 189 • NUMBER 6 • 2010   1010
using  the  Cytoscape  software  (version  2.6.3;  http://cytoscape.org/)   
using  an  algorithm  described  by  Yosef  et  al.  (2009).  The  following   
parameters were used when a BiNGO analysis (of Homo sapiens GO 
annotations) was performed: hypergeometric test, Benjamini-Hochberg 
false  discovery  rate  correction  (to  correct  for  multiple  testing),  signifi-
cance  value  0.001,  and  GO  biological  processes.  Each  cluster  was 
tested against the whole annotation.
Online supplemental material
Fig. S1 shows the distribution of ER-, mixed-, and Golgi-class hits in several 
signaling pathways. Fig. S2 shows the impact of NF1 or CNK1 knock-
downs on ERK1/2 activation. Fig. S3 shows the effect of Sec24A+B deple-
tion or ERK1 on budding of ERGIC-53. Table S1, included as an Excel file, 
contains a list of all kinases phosphatases that have been targeted and the 
ID numbers of the siRNAs that were used to target them. Table S2, included 
as an Excel file, contains a list of all 122 hits classified into ER-, mixed-, 
and Golgi-class hits and information about tubulin staining and the effect 
on the number of peripheral ERGIC punctae and cites evidence for the 
expression of the gene in HeLa cells. A zip file contains large PDF versions 
of the networks in Fig. 3 and their underlying data (which can be opened 
and visualized in Cytoscape). Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200912082/DC1.
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combinant active ERK2 (activated by purifying from cells expressing con-
stitutive active MEK1; Cell Signaling Technology) was added. The reaction 
was terminated by transferring the tubes to ice. Microsomes were col-
lected by centrifugation at 16,000 g for 10 min. The supernatant was 
centrifuged at 100,000 g for 40 min to pellet the budded vesicles. Bud-
ding efficiency was calculated as (V/MERGIC-53 × 100)  (V/MCLIMP63 × 100). 
To show that the budding assay for ERGIC-53 is COPII dependent, we 
performed budding assays with cytosol immunodepleted for Sec24A   
and -B (Wendeler et al., 2007).
Immunoprecipitation
For each immunoprecipitation experiment with GFP-tagged Sec16, three 
10-cm dishes (70% confluent cells) were used. Cells were transfected with 
GFP-tagged Sec16 cDNA. After 24 h, cells were lysed in 800 µl of immuno-
precipitation  buffer  (50  mM  Tris-HCl,  pH  7.4,  150  mM  NaCl,  2  mM 
CaCl2, and 1% Triton X-100). The lysate was incubated on ice for 10 min 
and cleared by centrifugation at 16,000 g for 10 min at 4°C. To the 
cleared lysate, protein G–Sepharose was added to which anti-GFP anti-
body had been preadsorbed. This mixture was incubated overnight with 
gentle agitation at 4°C. On the next day, the beads were washed three 
times, and Sec16 was eluted by boiling in sample buffer. For the kinase   
assay, the beads were washed thrice with kinase buffer (Cell Signaling 
Technology) and finally resuspended in 30 µl of this buffer.
Mutagenesis of Sec16
The following primer pair was used (the mutated triplet is underlined and 
bold):  Thr415Ile,  5-CGTGTCCCAGCCCTCAATTCCGAGCCCCCCG-3 
and 5-CGGGGGGCTCGGAATTGAGGGCTGGGACACG-3. A two-step 
PCR mutagenesis method was used. Two PCR reactions were performed in 
parallel, each containing only one primer. A typical PCR mixture (50 µl vol-
ume) contained 1 µl DNA (50 ng final), 1 µl Pfu polymerase, 5 µl of 10× 
buffer, 4 µl of primer (0.8 µM final concentration), 4 µl dNTP mixture (0.2 µM 
final concentration), and 35 µl water. The first PCR reaction was performed 
for 10 cycles (60 s at 95°C, 90 s at 55°C, and 21 min at 68°C). 25 µl of 
each reaction was then pooled, and 0.7 µl Pfu polymerase was added. 
The second PCR reaction was performed for 18 cycles with the same condi-
tions. PCR products were digested with DpnI for 3 h at 37°C and used to 
transform Escherichia coli. On the next day, colonies were picked and 
grown in 3-ml cultures overnight. 1 d later, plasmids were prepared using 
the GenElute Plasmid Miniprep kit (Sigma-Aldrich). All mutations were veri-
fied by sequencing.
Statistics
All data analysis was performed using Excel2003 (Microsoft). Error bars 
on all graphs are mean ± SD from three independent measurements, ex-
cept where indicated otherwise in the figures. Statistical significance was 
calculated using the t test, and P < 0.05 was considered significant.
Bioinformatic analysis
Interaction networks were generated using the STRING database. Only 
interactions supported by biochemical evidence or databases (including 
Kyoto Encyclopedia of Genes and Genomes, Reactome, and Pathway   
Interactin Database) were considered. Anchored networks were created 1011 MAPK signaling to the early secretory pathway • Farhan et al.
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